Impact of Multi-Component Intervention on Suspected Asthma Population

Status Not yet recruiting

Clinical Trial Summary

Study Participants: Suspected asthma population, defined as individuals whose score of asthma screening questionnaire used in ECRHS study exceeds 0 and whose age is 35 and above. Intervention: Within the intervention arm, we have constructed a population-based pay-for-performance mechanism to encourage medical practitioners to care for population health. For study participants in the intervention arm, we will ask them to finish an online ECRHS questionnaire with notification of his or her suspected asthma status. Individuals whose score of ECRHS asthma screening exceeds 0 will be given a face-to-face survey, simple physical examination, pulmonary function tests, and provide a multi-component intervention at baseline. For suspected asthma population in the intervention arm, we provide community-based spirometry pulmonary function test (PFT) and education; If individuals whose FEV1 improved by ≥12% and ≥200 mL following bronchodilator administration with 400 ug salbutamol, they will be spirometry-defined undiagnosed asthma patient and will be encouraged to seek treatment and medication to the superior hospitals. Additionally, we provide (1) two digital health intervention programs to smokers and individuals with mental health issues; (2) CBT-based health education for study participants with abnormal BMI; (3) active recruitment into National Essential Public Health Program in China for those with abnormal blood pressure and blood glucose. Intensive follow-ups will be conducted at month 3 (telephone interview), month 6 (face-to-face with full steps of physical examination), and month 12. Comparison: Those who are assigned in the control arm, we will ask them to finish the same ECRHS online questionnaire with notification of his or her suspected asthma status and a face-to-face survey. No physical examinations, community-based pulmonary function tests will be given. Outcomes: The primary outcomes are asthma knowledge, lung function testing, and ACT score at month 12.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06457009
Study type	Interventional
Source	Peking Union Medical College
Contact	Simiao Chen, Ph.D.
Phone	010-65104915
Email	simiao.chen@uni-heidelberg.de
Status	Not yet recruiting
Phase	N/A
Start date	June 17, 2024
Completion date	October 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05421143` - Co-design of a Seamless Person-centered Intervention to Optimize Medication Use Across Healthcare Levels
Completed	`NCT04942613` - Engaging Medically Complex Veterans in Tele-Rehabilitation Using a Biobehavioral Approach	N/A
Completed	`NCT02928939` - Therapeutic Conflicts and Multimorbidity
Recruiting	`NCT05560451` - Telehealth-delivered Peer Support to Improve Quality of Life Among Veterans With Multimorbidity	N/A
Completed	`NCT03697772` - Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients
Recruiting	`NCT03439410` - Clinical Complexity in Internal Medicine Wards. San MAtteo Complexity Study
Active, not recruiting	`NCT05985044` - Living With Multimorbidity: CO-ORDINATE Program	N/A
Completed	`NCT02866799` - Multi-PAP: Improving Prescription in Primary Care Patients With Multimorbidity and Polypharmacy	N/A
Recruiting	`NCT05406193` - A New Care Model for Patients With Complicated Multimorbidity	N/A
Completed	`NCT02962687` - Video-Enhanced Care Management for Medically Complex Veterans	N/A
Completed	`NCT02664454` - Compared Efficacy of Nurse-led and GP-led Geriatric Assessment in PrImary Care	N/A
Not yet recruiting	`NCT04391218` - A Multidisciplinary Intervention Including a Clinical Decision Support System and an App for Drug Therapy Management in Older Patients	N/A
Completed	`NCT03126565` - Evaluation of the Philips Lifeline CareSage Risk Assessment System	N/A
Recruiting	`NCT04856202` - ACP in Older Patients With Multimorbidity: a Randomized Pilot	N/A
Completed	`NCT03912103` - Interdisciplinary Medication Review Interventions in an Integrated Outpatient Department.	N/A
Completed	`NCT04955600` - Digital Technology in the Home of Elderly Patients With Multimorbidity
Completed	`NCT05893212` - Nature Walks or Exercise as a Group Activity, the Effect Well-being, Sleep and Activity.	N/A
Completed	`NCT03528005` - Effectiveness of Integrated Care Network	N/A
Completed	`NCT03088982` - Preventing Decompensation Among Multimorbid Outpatients in Residential Care. A Cohort Study With a Six-month Follow-up.	N/A
Not yet recruiting	`NCT06458218` - Impact of Multi-component Interventions on Populations With Mental Health Symptoms and High-risk COPD	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.